Fibroblast Supernatants Modulate Treatment Responses in Human Papillomavirus Positive and Negative Oropharyngeal Cancer Cell Lines

MADELEINE BIRGERSSON; TERÉZIA CHABANOVÁ; EMILIA WIECHEC; OURANIA N. KOSTOPOULOU; TINA DALIANIS

doi:10.21873/anticanres.17822

Article Information

vol. 45 no. 11 4729-4742

DOI

https://doi.org/10.21873/anticanres.17822

PubMed

41151878

Published By

International Institute of Anticancer Research

Print ISSN

0250-7005

Online ISSN

1791-7530

History

Received July 15, 2025
Revision received July 30, 2025
Accepted July 31, 2025
Published online October 28, 2025.

Copyright © 2025 The Author(s). Published by the International Institute of Anticancer Research. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Author Information

MADELEINE BIRGERSSON¹,
TERÉZIA CHABANOVÁ¹,
EMILIA WIECHEC²,³,
OURANIA N. KOSTOPOULOU¹ and
TINA DALIANIS¹,⁴ ⇑

¹Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;
²Region Östergötland Anaesthetics, Operations and Specialty Surgery Center, Department of Otorhinolaryngology, Linköping, Sweden;
³Division of Cell Biology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden;
⁴Medical Unit Head-, Neck-, Lung- and Skin Cancer Theme Cancer, Karolinska University Hospital Stockholm, Stockholm, Sweden

Tina Dalianis, Prof. MD, Ph.D., Department of Oncology-Pathology, Karolinska Institutet, Bioclinicum J6:20, Karolinska University Hospital, 171 64 Stockholm, Sweden. Tel: +46 707910297, e-mail: Tina.Dalianis{at}ki.se

View Full Text